Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
ViroMissile, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
University of Nebraska
National Cancer Institute (NCI)
AccSalus Biosciences, Inc.
Cancer Research UK
Day One Biopharmaceuticals, Inc.
Travera Inc
JS InnoPharm, LLC
University Health Network, Toronto